SARS-CoV-2 Nucleoprotein
SARS-CoV-2/COVID-19 Nucleoprotein is a recombinant protein expressed in E. coli.
The SARS-CoV-2 Nucleoprotein (also known as Nucleocapsid Protein or N Protein) is a protein that binds to the RNA in the viral particle. Changes to two amino acids in the nucleoprotein are thought to contribute to the virus’ ability to infect humans; this mutation allows the virus to reduce the binding capability of an HLA-C allele found in many Europeans. The nucleoprotein is the second most-common protein in SARS-CoV-2 targeted by the immune system, after the spike protein.
The SARS-CoV-2 Nucleoprotein (also known as Nucleocapsid Protein or N Protein) is a protein that binds to the RNA in the viral particle. Changes to two amino acids in the nucleoprotein are thought to contribute to the virus’ ability to infect humans; this mutation allows the virus to reduce the binding capability of an HLA-C allele found in many Europeans. The nucleoprotein is the second most-common protein in SARS-CoV-2 targeted by the immune system, after the spike protein.
Supplier | Abbexa Ltd. |
---|---|
Product # | abx655882-200UG |
Pricing | 200 µg USD $667.0 |
Conjugation | Unconjugated |
Host | E. coli |
Tested Applications | WB, SDS-PAGE |
Activity | Not tested |
Dry Ice | No |
Availability | Shipped within 5-15 working days. |
Note |
|